Viewing Study NCT02402660

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:14 AM

Ignite Modification Date: 2026-03-04 @ 10:46 AM

Study NCT ID: NCT02402660

Status: ENROLLING_BY_INVITATION

Last Update Posted: 2025-04-27

First Post: 2015-03-09

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Sponsor: Alkeus Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module